Autoimmune and inflammatory diseases following COVID-19

Abstract

Emerging reports show that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection precedes the appearance of various autoimmune and autoinflammatory diseases, including paediatric inflammatory multisystemic syndrome (PIMS) or multisystem inflammatory syndrome in children (MIS-C), thus adding to the growing mystery of this virus and raising questions about the nature of its link with autoimmune and autoinflammatory sequelae.

Read full text: Galeotti C, Bayry J. Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol. 2020 Jun 4:1–2. doi: 10.1038/s41584-020-0448-7. Epub ahead of print. PMID: 32499548; PMCID: PMC7271827.


 

Keywords: Paediatric rheumatic diseases, Autoimmunity, SARS-CoV-2, paediatric inflammatory multisystemic syndrome (PIMS), multisystem inflammatory syndrome in children (MIS-C), #Autoimmune, #Inflammatory, #COVID19.

The International Natural Product Sciences Taskforce (INPST) maintains up-to-date lists with conferencesgrants and funding opportunitiesjobs and open positions, and journal special issues with relevance for the area of phytochemistry and food chemistry, pharmacology, biotechnology, medicine and pharmacognosy research, and natural product science.

Join for free INPST as a member

INPST social media channels